Frank Clyburn - 26 Jun 2025 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
Director
Signature
/s/ Jack Anders, as Attorney-in-fact for Frank Clyburn
Issuer symbol
RVMD
Transactions as of
26 Jun 2025
Transactions value $
$0
Form type
4
Filing time
30 Jun 2025, 16:23:55 UTC
Previous filing
10 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Clyburn Frank Director C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DR, REDWOOD CITY /s/ Jack Anders, as Attorney-in-fact for Frank Clyburn 30 Jun 2025 0001763963

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Award $0 +2.81K +40.48% $0.00 9.74K 26 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Award $0 +10.3K $0.00 10.3K 26 Jun 2025 Common Stock 10.3K $37.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 8,005 Restricted Stock Units.
F2 Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.